For: | Durczynski A, Kumor A, Hogendorf P, Szymanski D, Grzelak P, Strzelczyk J. Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer. World J Gastroenterol 2014; 20(36): 13167-13171 [PMID: 25278712 DOI: 10.3748/wjg.v20.i36.13167] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i36/13167.htm |
Number | Citing Articles |
1 |
Dorothée Faille, Marie-Charlotte Bourrienne, Emmanuelle de Raucourt, Luc de Chaisemartin, Vanessa Granger, Romaric Lacroix, Laurence Panicot-Dubois, Pascal Hammel, Philippe Lévy, Philippe Ruszniewski, Nadine Ajzenberg, Vinciane Rebours. Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process. Oncotarget 2018; 9(41): 26453 doi: 10.18632/oncotarget.25458
|
2 |
Sanna Matilainen, Gilber Kask, Jyrki Nieminen, Riitta Lassila, Minna Laitinen. Preoperative coagulation biomarkers associate with survival and pulmonary embolism after surgical treatment of non-spinal skeletal metastases. Thrombosis Journal 2022; 20(1) doi: 10.1186/s12959-022-00431-w
|
3 |
Alicja Majos, Ewa Sewerynek, Oliwia Grząsiak, Wojciech Ciesielski, Piotr Hogendorf, Jarosław Hołyński, Janusz Strzelczyk, Adam Durczyński. FT3 to FT4 Conversion Ratio May Be an Independent Prognostic Factor in Pancreatic Cancer Patients. Biomedicines 2022; 11(1): 77 doi: 10.3390/biomedicines11010077
|
4 |
Junli Cao, Zhanzhao Fu, Liming Gao, Xin Wang, Shaohui Cheng, Xiuchao Wang, He Ren. Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma. World Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1104-9
|
5 |
Mulkyawan BAHRUN, Ibrahim LABEDA, Mappincara MAPPINCARA, Joko HENDARTO, Ronald E. LUSIKOOY, Warsinggih WARSINGGIH, Samuel SAMPETODING, Muhammad I. KUSUMA, Julianus A. UWURATUW, Erwin SYARIFUDDIN, Muhammad FARUK. Plasma D-dimer and urine D-dimer are associated with resectability of pancreatic cancer. Chirurgia 2023; 36(6) doi: 10.23736/S0394-9508.23.05538-9
|
6 |
Cristina Jimenez-Luna, Carolina Torres, Raul Ortiz, Carmelo Dieguez, Joaquina Martinez-Galan, Consolacion Melguizo, Jose C. Prados, Octavio Caba. Proteomic biomarkers in body fluids associated with pancreatic cancer. Oncotarget 2018; 9(23): 16573 doi: 10.18632/oncotarget.24654
|
7 |
Florian Moik, Gerald Prager, Johannes Thaler, Florian Posch, Sarah Wiedemann, Theresa Schramm, Cornelia Englisch, Nigel Mackman, Ingrid Pabinger, Cihan Ay. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer. Arteriosclerosis, Thrombosis, and Vascular Biology 2021; 41(11): 2837 doi: 10.1161/ATVBAHA.121.316463
|
8 |
Mashio Nakamura, Masato Sakon, Mitsuru Sasako, Takuji Okusaka, Hirofumi Mukai, Keiichi Fujiwara, Hideo Kunitoh, Mari S. Oba, Hideo Wada, Jun Hosokawa, Atsushi Takita, Masataka Ikeda. Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis. International Journal of Clinical Oncology 2024; 29(4): 407 doi: 10.1007/s10147-024-02475-6
|
9 |
Adam Durczynski, Anna Kumor, Piotr Grzelak, Marcin Strzelczyk, Piotr Hogendorf, Grazyna Poznanska, Aleksander Skulimowski, Dariusz Szymanski, Janusz Strzelczyk. Concentration of D-dimers in Bile—a Novel Marker of Pancreatic Cancer Enhancing Accuracy of Standard CA19-9 Measurement. Pancreas 2017; 46(1): e9 doi: 10.1097/MPA.0000000000000696
|
10 |
Marina Marchetti, Anna Falanga. Hemostatic biomarkers in occult cancer and cancer risk prediction. Thrombosis Research 2020; 191: S37 doi: 10.1016/S0049-3848(20)30395-9
|
11 |
Haoda Chen, Fanlu Li, Siyi Zou, Junjie Xie, Jun Zhang, Xiaxing Deng, Hao Chen, Baiyong Shen. Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02281-8
|
12 |
Hadi M.H. Diab, Henry G. Smith, Kristian K. Jensen, Lars N. Jørgensen. The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: A systematic review. European Journal of Cancer 2021; 154: 73 doi: 10.1016/j.ejca.2021.05.033
|
13 |
Carla F. Pereira, M. Goreti F. Sales, Manuela F. Frasco. A molecularly imprinted photonic polymer based on an inverse opal structure for sensing D-dimer at the point-of-care. Talanta 2022; 243: 123387 doi: 10.1016/j.talanta.2022.123387
|
14 |
Bin Wu, Guangming Zhang, Xiashuang Zhao, Jie Wang, Da Wang, Yipeng Zhang, Miao Yu, Hui Cai. Association between D-dimer levels and clinicopathological characteristics of pancreatic cancer and its role in prognosis: A systematic review and meta-analysis. Asian Journal of Surgery 2024; 47(8): 3417 doi: 10.1016/j.asjsur.2024.02.043
|
15 |
Alicja Strzałka, Piotr Hogendorf, Aleksander Skulimowski, Michał Spychalski, Janusz Strzelczyk, Adam Durczynski. Thyroid hormones concentration in portal and peripheral blood in patients with pancreatic cancer: Preliminary study. Cancer Biomarkers 2020; 29(3): 301 doi: 10.3233/CBM-201595
|
16 |
Adam Durczynski, Aleksander Skulimowski, Piotr Hogendorf, Dariusz Szymanski, Anna Kumor, Konrad Marski, Siri Øvereng Juliebø, Grazyna Poznanska, Janusz Strzelczyk. The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer. World Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1291-4
|
17 |
Xinchun Liu, Yue Fu, Qiuyang Chen, Junli Wu, Wentao Gao, Kuirong Jiang, Yi Miao, Jishu Wei. Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0891-y
|
18 |
Nora Mattila, Hanna Seppänen, Harri Mustonen, Beata Przybyla, Caj Haglund, Riitta Lassila. Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma. Clinical and Applied Thrombosis/Hemostasis 2018; 24(8): 1267 doi: 10.1177/1076029618779133
|
19 |
Iranzu González-Borja, Antonio Viúdez, Saioa Goñi, Enrique Santamaria, Estefania Carrasco-García, Jairo Pérez-Sanz, Irene Hernández-García, Pablo Sala-Elarre, Virginia Arrazubi, Esther Oyaga-Iriarte, Ruth Zárate, Sara Arévalo, Onintza Sayar, Ruth Vera, Joaquin Fernández-Irigoyen. Omics Approaches in Pancreatic Adenocarcinoma. Cancers 2019; 11(8): 1052 doi: 10.3390/cancers11081052
|
20 |
Jing Yu, Dongqing Li, Dansheng Lei, Feng Yuan, Feng Pei, Huifeng Zhang, Anming Yu, Kun Wang, Hu Chen, Liang Chen, Xianglei Wu, Xianli Tong, Yefu Wang, Robert Hurst. Tumor-Specific D-Dimer Concentration Ranges and Influencing Factors: A Cross-Sectional Study. PLOS ONE 2016; 11(11): e0165390 doi: 10.1371/journal.pone.0165390
|
21 |
Aneta Szmiel, Alicja Majos, Wojciech Ciesielski, Anna Kumor, Janusz Strzelczyk, Krzysztof Szwedziak, Piotr Hogendorf, Adam Durczyński. Gender-Specific Coagulation Profiles of Peripheral and Portal Blood May Help to Differentiate Malignant from Benign Pancreatic Tumour—Pilot Study. Journal of Clinical Medicine 2022; 11(6): 1573 doi: 10.3390/jcm11061573
|
22 |
O. I. Kit, E. M. Frantsiyants, O. V. Katelnitskaya. Risk of venous thromboembolism in patients with pancreatic cancer. Siberian journal of oncology 2022; 21(3): 24 doi: 10.21294/1814-4861-2022-21-3-24-32
|
23 |
Arturs Silovs, Ilze Strumfa, Reinis Riekstins, Zane Simtniece, Andrejs Vanags, Janis Gardovskis. Advances in Pancreatic Cancer. 2018; doi: 10.5772/intechopen.78954
|
24 |
Monika Wójcik-Giertuga, Anna Malczewska-Herman, Beata Kos-Kudła. The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms. Cancers 2023; 15(22): 5477 doi: 10.3390/cancers15225477
|